H.C. Wainwright maintained a neutral stance on Eyenovia (NASDAQ:EYEN) shares, reiterating a price target of $2.00. The firm's analyst, Matthew Caufield, highlighted the U.S. Food and Drug ...

Plymouth Industrial REIT, Inc. (NYSE: PLYM) is a full service, vertically integrated real estate investment company focused on the acquisition, ownership and management of single and multi-tenant ...

Rigorous testing has resulted in observations of the Optejet’s durable base unit performing over 30,000 sprays, and 98% of ...

Eyenovia (EYEN) announces recent progress on the development of its user-filled spray dispenser. “Millions of consumers have difficulty with ...

NEW YORK – Eyenovia, Inc., a pharmaceutical company specializing in preparations, announced today a reverse stock split of its common shares in a strategic move to comply with Nasdaq's minimum bid ...

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Eyenovia, Inc. (NASDAQ: EYEN) ("Eyenovia" or the "Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet ...

Qsic, the global intelligent in-store audio platform that elevates the in-store experience and drives incremental revenue, ...

Virtual meeting scheduled for 10:00 a.m. ET on January 21st; stockholders must pre-register by 11:59 p.m. ET on January 20thNEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) ...